AAPL315.62-0.60 (-0.19%) ▼|ABBV250.37+1.59 (+0.64%) ▲|ABT105.40-0.12 (-0.11%) ▼|ACN177.31-1.72 (-0.96%) ▼|ADBE255.49-1.78 (-0.69%) ▼|AMAT467.78-5.01 (-1.06%) ▼|AMD519.22+13.48 (+2.67%) ▲|AMGN392.11-1.07 (-0.27%) ▼|AMT175.37-0.37 (-0.21%) ▼|AMZN252.15-4.83 (-1.88%) ▼|AVGO363.76-4.81 (-1.30%) ▼|AXP322.54-3.57 (-1.09%) ▼|BA208.00-2.73 (-1.30%) ▼|BAC62.90+0.51 (+0.81%) ▲|BKNG173.08-7.23 (-4.01%) ▼|BLK1,075.34-20.04 (-1.83%) ▼|BMY64.31-0.39 (-0.60%) ▼|BNY163.26+0.41 (+0.25%) ▲|BRK-B507.31+1.48 (+0.29%) ▲|C138.43+1.69 (+1.23%) ▲|CAT818.05-4.43 (-0.54%) ▼|CL88.02-0.39 (-0.44%) ▼|CMCSA24.56-1.77 (-6.72%) ▼|COF212.55-1.42 (-0.66%) ▼|COP137.24+2.20 (+1.63%) ▲|COST901.49-8.69 (-0.95%) ▼|CRM244.28-4.85 (-1.94%) ▼|CSCO109.28+0.11 (+0.10%) ▲|CVS95.82-0.25 (-0.26%) ▼|CVX214.01+4.21 (+2.01%) ▲|DE677.21-3.53 (-0.52%) ▼|DHR205.08-0.15 (-0.07%) ▼|DIS104.43-0.63 (-0.60%) ▼|DUK120.32-0.92 (-0.76%) ▼|EMR151.08-1.07 (-0.70%) ▼|FDX310.14-3.99 (-1.27%) ▼|GD352.72-3.87 (-1.08%) ▼|GE326.49-8.42 (-2.52%) ▼|GEV953.40-17.91 (-1.84%) ▼|GILD145.74-0.90 (-0.61%) ▼|GM84.75-1.04 (-1.21%) ▼|GOOG328.54-6.85 (-2.04%) ▼|GOOGL330.99-7.38 (-2.18%) ▼|GS1,031.66-4.87 (-0.47%) ▼|HD311.17-2.53 (-0.81%) ▼|HON205.26-2.98 (-1.43%) ▼|IBM239.46+7.37 (+3.18%) ▲|INTC106.23+1.76 (+1.68%) ▲|INTU314.34-4.59 (-1.44%) ▼|ISRG352.63+2.47 (+0.71%) ▲|JNJ267.95-1.17 (-0.43%) ▼|JPM355.39+1.88 (+0.53%) ▲|KO87.79-0.58 (-0.65%) ▼|LIN466.02-2.36 (-0.50%) ▼|LLY1,125.26+1.35 (+0.12%) ▲|LMT526.31-9.84 (-1.84%) ▼|LOW198.71-2.09 (-1.04%) ▼|LRCX314.93-5.50 (-1.71%) ▼|MA569.83-1.06 (-0.19%) ▼|MCD254.55-1.26 (-0.49%) ▼|MDLZ62.28+0.65 (+1.05%) ▲|MDT92.07-0.32 (-0.35%) ▼|META655.08+41.60 (+6.78%) ▲|MMM164.39-3.13 (-1.87%) ▼|MO67.83-0.34 (-0.50%) ▼|MRK147.81-0.65 (-0.44%) ▼|MS215.92-0.32 (-0.15%) ▼|MSFT491.59-2.37 (-0.48%) ▼|MU1,029.05+28.79 (+2.88%) ▲|NEE83.08-0.76 (-0.90%) ▼|NFLX76.13-0.64 (-0.83%) ▼|NKE37.26-0.85 (-2.22%) ▼|NOW131.85-2.36 (-1.76%) ▼|NVDA223.79-1.94 (-0.86%) ▼|ORCL162.64+0.12 (+0.07%) ▲|PEP137.14-1.31 (-0.94%) ▼|PFE27.81+0.02 (+0.07%) ▲|PG142.74-2.84 (-1.95%) ▼|PLTR170.33+0.03 (+0.01%) ▲|PM185.58+0.85 (+0.46%) ▲|QCOM175.42+1.33 (+0.76%) ▲|RTX198.14-0.67 (-0.34%) ▼|SBUX100.60-1.41 (-1.38%) ▼|SCHW106.74-0.14 (-0.13%) ▼|SO88.46-0.54 (-0.60%) ▼|SPG205.58-4.06 (-1.93%) ▼|T25.17-0.43 (-1.68%) ▼|TMO608.81+5.79 (+0.96%) ▲|TMUS177.96-3.73 (-2.05%) ▼|TSLA369.13+0.97 (+0.26%) ▲|TXN260.83+1.91 (+0.74%) ▲|UBER71.30-1.84 (-2.51%) ▼|UNH392.25-8.59 (-2.14%) ▼|UNP285.01-3.44 (-1.19%) ▼|UPS99.44-1.04 (-1.04%) ▼|USB62.26-0.24 (-0.38%) ▼|V368.61-0.03 (-0.01%) ▼|VZ49.76-0.65 (-1.29%) ▼|WFC89.77+1.81 (+2.05%) ▲|WMT105.91-0.14 (-0.13%) ▼|XOM164.05+3.39 (+2.11%) ▲|AAPL315.62-0.60 (-0.19%) ▼|ABBV250.37+1.59 (+0.64%) ▲|ABT105.40-0.12 (-0.11%) ▼|ACN177.31-1.72 (-0.96%) ▼|ADBE255.49-1.78 (-0.69%) ▼|AMAT467.78-5.01 (-1.06%) ▼|AMD519.22+13.48 (+2.67%) ▲|AMGN392.11-1.07 (-0.27%) ▼|AMT175.37-0.37 (-0.21%) ▼|AMZN252.15-4.83 (-1.88%) ▼|AVGO363.76-4.81 (-1.30%) ▼|AXP322.54-3.57 (-1.09%) ▼|BA208.00-2.73 (-1.30%) ▼|BAC62.90+0.51 (+0.81%) ▲|BKNG173.08-7.23 (-4.01%) ▼|BLK1,075.34-20.04 (-1.83%) ▼|BMY64.31-0.39 (-0.60%) ▼|BNY163.26+0.41 (+0.25%) ▲|BRK-B507.31+1.48 (+0.29%) ▲|C138.43+1.69 (+1.23%) ▲|CAT818.05-4.43 (-0.54%) ▼|CL88.02-0.39 (-0.44%) ▼|CMCSA24.56-1.77 (-6.72%) ▼|COF212.55-1.42 (-0.66%) ▼|COP137.24+2.20 (+1.63%) ▲|COST901.49-8.69 (-0.95%) ▼|CRM244.28-4.85 (-1.94%) ▼|CSCO109.28+0.11 (+0.10%) ▲|CVS95.82-0.25 (-0.26%) ▼|CVX214.01+4.21 (+2.01%) ▲|DE677.21-3.53 (-0.52%) ▼|DHR205.08-0.15 (-0.07%) ▼|DIS104.43-0.63 (-0.60%) ▼|DUK120.32-0.92 (-0.76%) ▼|EMR151.08-1.07 (-0.70%) ▼|FDX310.14-3.99 (-1.27%) ▼|GD352.72-3.87 (-1.08%) ▼|GE326.49-8.42 (-2.52%) ▼|GEV953.40-17.91 (-1.84%) ▼|GILD145.74-0.90 (-0.61%) ▼|GM84.75-1.04 (-1.21%) ▼|GOOG328.54-6.85 (-2.04%) ▼|GOOGL330.99-7.38 (-2.18%) ▼|GS1,031.66-4.87 (-0.47%) ▼|HD311.17-2.53 (-0.81%) ▼|HON205.26-2.98 (-1.43%) ▼|IBM239.46+7.37 (+3.18%) ▲|INTC106.23+1.76 (+1.68%) ▲|INTU314.34-4.59 (-1.44%) ▼|ISRG352.63+2.47 (+0.71%) ▲|JNJ267.95-1.17 (-0.43%) ▼|JPM355.39+1.88 (+0.53%) ▲|KO87.79-0.58 (-0.65%) ▼|LIN466.02-2.36 (-0.50%) ▼|LLY1,125.26+1.35 (+0.12%) ▲|LMT526.31-9.84 (-1.84%) ▼|LOW198.71-2.09 (-1.04%) ▼|LRCX314.93-5.50 (-1.71%) ▼|MA569.83-1.06 (-0.19%) ▼|MCD254.55-1.26 (-0.49%) ▼|MDLZ62.28+0.65 (+1.05%) ▲|MDT92.07-0.32 (-0.35%) ▼|META655.08+41.60 (+6.78%) ▲|MMM164.39-3.13 (-1.87%) ▼|MO67.83-0.34 (-0.50%) ▼|MRK147.81-0.65 (-0.44%) ▼|MS215.92-0.32 (-0.15%) ▼|MSFT491.59-2.37 (-0.48%) ▼|MU1,029.05+28.79 (+2.88%) ▲|NEE83.08-0.76 (-0.90%) ▼|NFLX76.13-0.64 (-0.83%) ▼|NKE37.26-0.85 (-2.22%) ▼|NOW131.85-2.36 (-1.76%) ▼|NVDA223.79-1.94 (-0.86%) ▼|ORCL162.64+0.12 (+0.07%) ▲|PEP137.14-1.31 (-0.94%) ▼|PFE27.81+0.02 (+0.07%) ▲|PG142.74-2.84 (-1.95%) ▼|PLTR170.33+0.03 (+0.01%) ▲|PM185.58+0.85 (+0.46%) ▲|QCOM175.42+1.33 (+0.76%) ▲|RTX198.14-0.67 (-0.34%) ▼|SBUX100.60-1.41 (-1.38%) ▼|SCHW106.74-0.14 (-0.13%) ▼|SO88.46-0.54 (-0.60%) ▼|SPG205.58-4.06 (-1.93%) ▼|T25.17-0.43 (-1.68%) ▼|TMO608.81+5.79 (+0.96%) ▲|TMUS177.96-3.73 (-2.05%) ▼|TSLA369.13+0.97 (+0.26%) ▲|TXN260.83+1.91 (+0.74%) ▲|UBER71.30-1.84 (-2.51%) ▼|UNH392.25-8.59 (-2.14%) ▼|UNP285.01-3.44 (-1.19%) ▼|UPS99.44-1.04 (-1.04%) ▼|USB62.26-0.24 (-0.38%) ▼|V368.61-0.03 (-0.01%) ▼|VZ49.76-0.65 (-1.29%) ▼|WFC89.77+1.81 (+2.05%) ▲|WMT105.91-0.14 (-0.13%) ▼|XOM164.05+3.39 (+2.11%) ▲|
28.6 C
New York
Wednesday, September 9, 2026

Tag: litigation

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 7, 2026.

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”), of the important July 20, 2026 lead plaintiff deadline.

PHREESIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PHR

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”), of the important July 13, 2026 lead plaintiff deadline.

Attorney John Gomez Announces Whistleblower Retaliation Lawsuit on Behalf of Former Albert Einstein Academies Principal

Former Principal Margaretta Boutserse alleges she was terminated after refusing to participate in efforts aimed at undermining teacher unionization.By Shane Harris, Director of Communications,...

BABCOCK & WILCOX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors to Secure Counsel Before Important June 15 Deadline in...

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Babcock & Wilcox Enterprises, Inc. (“B&W”) (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the “Class Period”), of the important June 15, 2026 lead plaintiff deadline.

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation – TBRG

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public.

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

INDIANAPOLIS, June 13, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that...

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

BTGO EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BitGo To Contact Him Directly To Discuss Their Options

CALX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Calix (CALX) Investors of Securities Class Action Lawsuit Deadline on July 27, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Calix To Contact Him Directly To Discuss Their Options

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --

AIFA 就涉及 HyalRoute Communication Group Limited 的股份收購交易正式作出澄清及反駁

紐約, June 13, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance Inc. (Nasdaq: AIFA)(「公司」或「AIFA」)近日發現,HyalRoute Communication Group Limited(「HyalRoute」)的現任管理團隊以 Dong 女士個人名義,並透過若干柬埔寨媒體及社交媒體渠道,發表或轉發言論,指公司於 2026 年 5 月 22 日有關收購 HyalRoute 控股權益的公告屬「虛假」或「捏造」。

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLitigation